Public Policy

*Editors Note: Data provided in an early version of the press release was incorrect related to the number of people worldwide being treated for rare diseases. These conditions affect 25-30 million people in the U.S. and 350 million worldwide. Published: May 19, 2021, 8:00 a.m. U.S. Eastern Time Media Contact: Kara Flynn, 202.257.8424, press@ashg.org   Economic Analysis Shows... Read More

Dear ASHG Members, Today ASHG is releasing a new report on how human genetics and genomics is growing the U.S. economy and becoming increasingly integrated in healthcare and society. The new report, titled “The Economic Impact and Functional Applications of Human Genetics and Genomics,” indicates that the human genetics and genomics sector contributes $265 billion... Read More

Posted By: Lyly Luhachack, PhD, Policy & Advocacy Specialist, ASHG April 22, 2021, marked the first-ever ASHG Capitol Hill Day. The Government and Public Advocacy Committee (GPAC), ASHG President Gail Jarvik, MD, PhD, Dana Crawford, PhD, Diversity, Equity, and Inclusion Task Force (DEITF) Chair, and leaders of the Career Development Committee (CDC) met, virtually, with... Read More

Published: Thursday, April 22, 2021, 4:30 p.m. U.S. Eastern Time Media Contact: Kara Flynn, 202.257.8424, press@ashg.org ROCKVILLE, MD – Earlier today, the American Society of Human Genetics (ASHG) hosted its first ever Hill Day. Due to the continued impacts of the COVID-19 pandemic, Hill Day 2021 was hosted virtually, making advocating for geneticists more accessible than ever.... Read More

ASHG supports the nomination of Eric Lander, PhD, to lead the Office of Science and Technology Policy (OSTP).  The announcement of the new team at the dawn of President Biden’s presidency, and elevating the Director of OSTP to a Cabinet position, is a positive sign that science, and scientists, will have a core role in... Read More